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Abstract
Aim: To investigate the effects of inotropic agents on parameters of tissue perfusion in patients with cardiogenic shock.
Methods and Results: Thirty patients with cardiogenic shock were included. Patients received dobutamine, enoximone, or
norepinephrine. We performed hemodynamic measurements at baseline and after titration of the inotropic agent until
cardiac index (CI) $2.5 L.min21.m22 or mixed-venous oxygen saturation (SvO2) $70% (dobutamine or enoximone), and
mean arterial pressure (MAP) $70 mmHg (norepinephrine). As parameters of tissue perfusion, we measured central-
peripheral temperature gradient (delta-T) and sublingual perfused capillary density (PCD). All patients reached predefined
therapeutic targets. The inotropes did not significantly change delta-T. Dobutamine did not change PCD. Enoximone
increased PCD (9.1 [8.9–10.2] vs. 11.4 [8.4–13.9] mm.mm22; p,0.05), and norepinephrine tended to decrease PCD (9.8 [8.5–
11.9] vs. 8.8 [8.2–9.6] mm.mm22, p = 0.08). Fifteen patients (50%) died within 30 days after admission. Patients who had low
final PCD (#10.3 mm.mm22; 64%) were more likely to die than patients who had preserved PCD (.10.3 mm.mm22;
mortality 72% vs. 17%, p = 0.003).
Conclusion: This study demonstrates the effects of commonly used inotropic agents on parameters of tissue perfusion in
patients with cardiogenic shock. Despite hemodynamic optimization, tissue perfusion was not sufficiently restored in most
patients. In these patients, mortality was high. Interventions directed at improving microcirculation may eventually help
bridging the gap between improved hemodynamics and dismal patient outcome in cardiogenic shock.
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Introduction
Patients with cardiogenic shock are at risk for impaired
perfusion of organs and tissues. Low peripheral skin temperature
as well as impaired sublingual tissue perfusion have been
associated with multiple organ failure and adverse outcome in
hemodynamically compromised patients [1,2,3,4,5]. Inotropic
agents have the potential to maintain or restore adequate end-
organ perfusion and function, but their use in heart failure has
been associated with increased myocardial oxygen demand and
cardiac arrhythmias [6]. Nevertheless, inotropic therapy is often
considered necessary in patients with cardiogenic shock to improve
the hemodynamic status; more specifically to increase cardiac
output, to decrease pulmonary capillary wedge pressure, and to
increase mean arterial pressure [7,8,9]. Pharmacologic treatment
of patients with cardiogenic shock has several clinical challenges.
First, the utility of inotropic therapy in restoring end-organ
perfusion in patients with cardiogenic shock is based primarily on
clinical experience rather than clinical trial data [6]. However,
clinical examination may be inaccurate in identifying patients with
low output states and impaired organ perfusion [10]. Second,
global hemodynamic parameters do not reflect differential
patterns of regional organ blood flow or compromised tissue
perfusion of the splanchnic bed associated with shock states. For
example, mean arterial blood pressure is often clinically used as a
surrogate marker for tissue perfusion. However, not all patients
with low output states present with hypotension and not all
patients with hypotension have impaired organ perfusion [10,11].
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This is further demonstrated by the results of the ESCAPE trial
that did not support the routine use of pulmonary artery catheter
guided therapy in acute heart failure [12]. Therefore, there is a
great need for techniques that directly assess tissue perfusion in
patients at the bedside [13]. These novel techniques should
provide guidance for the evaluation of existing and future
vasoactive therapies for acute heart failure syndromes and may
be the key to understand the interventions required to reduce the
morbidity and mortality associated with multiple organ failure in
patients with cardiogenic shock. We hypothesized that current
hemodynamic resuscitation based on classic hemodynamic
parameters would fail to improve microcirculation in at least a
subset of patients. Aim of this pilot study was further to elucidate
whether the effects of inotropic therapy on microcirculation could
be monitored by parameters of tissue perfusion, including
sublingual microcirculation as a surrogate for splanchnic perfu-
sion.
Methods
Study design
This observational study was conducted at the Intensive
Cardiac Care Unit of the Thoraxcenter, Erasmus University
Medical Center, the Netherlands. The study population consisted
of a subgroup of a cohort described previously [5]. All patients had
acute myocardial infarction, complicated by cardiogenic shock. A
patient was included in the current study when routine hemody-
namic resuscitation maneuvers were performed and an investiga-
tor was present to perform the measurements. Cardiogenic shock
was defined as echocardiographic evidence of cardiac dysfunction
(poor left and/or right ventricular function or severe mitral
regurgitation) and clinical signs of hypoperfusion (cold extremities,
oliguria or altered mental state), after adequate fluid resuscitation,
i.e. pulmonary capillary wedge pressure (PCWP) $18 mm Hg or
no further increase of cardiac output after a fluid challenge.
Patients with oral bleeding were excluded from the study since this
would have hampered the measurements. The Erasmus MC
medical ethical committee approved the protocol, and written
informed consent was obtained from each patient or, in case of
patients who were sedated, from a relative authorized to consent
on behalf of such a patient.
Hemodynamic monitoring
All patients were monitored with a radial artery catheter
(arterial cannula with FloSwitch, Ohmeda, Swindon, UK) and a
pulmonary artery catheter (Criticath SP5107H, Becton Dickinson,
Sandy, UT, USA or CCOmbo, Edwards Lifesciences, Saint-Prex,
Switzerland). Data collection included central body temperature
(measured at the tip of the pulmonary artery catheter), heart rate
(HR), mean arterial pressure (MAP), central venous pressure
(CVP), PCWP, mean pulmonary artery pressure (PAP), cardiac
index (CI), systemic vascular resistance (SVR), and mixed-venous
oxygen saturation (SvO2). SVR was calculated as (MAP-
CVP)*80/cardiac output. When no pulmonary artery catheter
was present, we estimated cardiac index from central venous
oxygen saturation (right atrium, Cuschieri formula [14]).
Microcirculatory assessment and analysis
Central-peripheral temperature gradient (delta-T) was defined
and calculated as the difference between central blood and skin
temperature. Central blood temperature was measured with a
pulmonary artery catheter or urinary bladder catheter. Skin
temperature was measured with a probe sticked on the dorsum of
the uncovered foot under constant room temperature (i.e. 21.0
degrees Celsius; temperature probe 170075; Ellab Inc., Centen-
nial, CO, USA).
The Sidestream Dark Field (SDF) imaging device (MicroScan;
Microvision Medical, Amsterdam, The Netherlands) was used to
obtain 2-dimensional video images of sublingual microcirculatory
blood flow. This technique has been described previously [15]. In
short, the camera emits green light that is absorbed by red blood
cells within microvessels. In this way, red blood cells are used as
the contrast agent to visualize sublingual blood flow in patent
microvessels. Per time point, three steady high-quality video
sequences of at least 20 secs duration were obtained and stored on
a laptop. Video files were then renamed using a randomly
allocated number and analyzed blindly. Quantification of the
images was done using dedicated software (Automated Vascular
Analysis (AVA) 3.0, MicrovisionMedical, Amsterdam, the Nether-
lands). Perfused capillary density (PCD) was calculated by
automated measuring the total length of perfused capillaries
divided by image area. Capillaries were defined as microvessels
with a diameter less than 20 mm. Capillaries were regarded as
perfused if they had either of the following flow classifications
obtained by visual inspection: sluggish, continuous or hyperdy-
namic [16]. Since SDF imaging enables visualization of flowing
intravascular erythrocytes rather than microvessel walls, an
increase in PCD was regarded as capillary recruitment. SDF
imaging has been shown to be superior to conventional orthogonal
polarization spectral imaging [15]. The AVA software has been
validated using videos of simulated microvascular flow as well as
using videos obtained from intensive care patients [17,18]. Hubble
et al reported an intraobserver variability of ,6% and an
interobserver variability of ,13% for all measures of small vessels
(capillaries) [19]. PCD measurements are reproducible with low
variability in patients with severe heart failure [20].
Study protocol
All measurements were performed within 24 hours after hospital
admission. To minimize the effect of regression to the mean due to
spontaneous variation in microcirculatory perfusion, two series of
baseline measurements were performed with a time interval of
15 minutes. Values from both baseline measurements were
averaged to obtain single baseline values. Reference values for
sublingual PCD in control patients (i.e. patients awaiting cardiac
surgery who were not in shock) have been reported previously, i.e.
$11.7 mm.mm22 ($2.5 percentile) [21]. Reference values for
sublingual PCD, associated with poor outcome in patients with
cardiogenic shock, were reported as #10.3 mm.mm22 [5].
The decision to start dobutamine, enoximone or norepineph-
rine was made by the attending physician. Dobutamine or
enoximone, depending on preference of the attending physician,
were given when cardiac index (CI) was ,2.2 L.min21.m22 or
when mixed-venous oxygen saturation (SvO2) was ,65%. Both
inotropic agents were only administered when mean arterial
pressure (MAP) was $60 mm Hg. Dobutamine and enoximone
were up titrated until the following targets had been reached: CI
$2.5 L.min21.m22 or SvO2 $70%. Norepinephrine was given to
patients when (MAP) was ,60 mm Hg, independent of CI or
SvO2. Norepinephrine was up titrated until MAP $70 mmHg.
After the second baseline measurement, the inotropic agent was
given as a bolus equal to the volume of the used intravenous line.
Immediately thereafter, a continuous intravenous infusion was
started and titrated. All measurements were repeated 10 minutes
(dobutamine or norepinephrine) or 30 minutes (enoximone) after
the maximum infusion rate had been started. During the study
period, dosages of other vasoactive medications were kept
constant. All components of the Sequential Organ Failure
Effects of Inotropes on Microcirculation in Cardiogenic Shock
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Assessment (SOFA) score were calculated, with the exception of
the central nervous system parameters, because the majority of the
patients received central nervous system depressant drugs at the
time of evaluation.
Statistical analysis
Categorical variables are presented as absolute numbers with
percentages. All continuous variables are presented as median and
interquartile range (IQR). Differences between groups were tested
with the chi-square test, the Mann-Whitney test or the Kruskal-
Wallis test, when appropriate. Changes between time points were
tested with the Wilcoxon signed ranks test. Correlations between
variables were investigated with Spearman’s correlation test.
Thirty-day mortality was stratified according to low PCD (ie,
#10.3 mm.mm22) or preserved PCD (ie, .10.3 mm.mm22),
according to a previous publication [5]. A p-value,0.05 was
regarded statistically significant.
Results
Study population
Thirty patients with cardiogenic shock were included in this
study, in whom 33 measurements were performed (Table 1).
Fourteen patients received dobutamine (dobu), 10 patients
received enoximone (enox), and 9 patients received norepineph-
rine (nor). There were no differences in baseline characteristics
between the groups (Table 1). The following maximum dosages of
intropic agents were administered: 5.0 [5.0–5.6] mg.kg21.min21
(dobu), 2.0 [2.0–2.0] mg.kg21.min21 (enox), and 0.12 [0.04–0.21]
mg.kg21.min21 (nor). Predefined hemodynamic targets for the
administered vaso-active medications were reached after 60 [56–
75] minutes (dobu), 85 [60–131] minutes (enox), and 75 [35–78]
minutes (nor). No inotrope-induced arrhythmias occurred during
execution of the study.
Effects on systemic and pulmonary circulation
There were no significant differences in global hemodynamic or
microcirculatory parameters between the two baseline measure-
ments within each group, indicating that patients were in a stable
condition before the inotropic agent was started. Baseline
hemodynamic parameters were not significantly different between
patients receiving dobutamine or enoximone. However, patients
treated with norepinephrine had a lower baseline MAP (p= 0.006,
Table 2).
Absolute changes in parameters are shown in Table 3. Figure 1
shows the changes in PCD at the individual patient level.
Dobutamine increased HR, decreased PCWP, increased CI and
SvO2, and lowered lactate concentration. Enoximone decreased
CVP en PCWP. Norepinephrine increased MAP and SVR.
(Table 3).
Effects on microcirculation
Baseline delta-T and PCD were not significantly different
between patients receiving the various inotropic agents (Table 2).
Figure 1 shows the changes in PCD at the individual patient level.
Delta-T was not significantly changed by dobutamine, enoximone,
or norepinephrine (Table 3). Dobutamine did not change PCD.
Enoximone increased PCD (9.1 [8.9–10.2] vs. 11.4 [8.4–13.9]
mm.mm22; p,0.05), and norepinephrine tended to decrease PCD
(9.8 [8.5–11.9] vs. 8.8 [8.2–9.6] mm.mm22, p = 0.08, Table 3).
After up titrating vasoactive therapy, 21 patients (64%) had still
low PCD values, ie #10.3 mm.mm22 (Figure 1).
Correlations
Table 4 demonstrates modest correlations between (pooled)
changes in global hemodynamic parameters and (pooled) changes
in delta-T and PCD. Especially in patients receiving norepineph-
rine, an increase in MAP was correlated to worsening of
microcirculatory parameters (Spearman’s rho= 0.60, p = 0.05 for
delta-T and Spearman’s rho=20.70, p = 0.04 for PCD). Neither
baseline delta-T nor baseline PCD were directly correlated to
lactate levels at both time points. However, patients with low
baseline PCD (,=10.3 mm.mm22) had higher baseline lactate
levels (2.1 [1.3–3.8] vs. 1.1 [1.0–1.4] mmol/L, p = 0.03) as
compared to patients with high baseline PCD. Changes in delta-
T or PCD did not predict changes in lactate. Finally, changes in
delta-T were correlated to changes in PCD (rho=20.50,
p = 0.01).
Outcome
Fifteen patients (50%) died within 30 days after admission.
Patients who had low final PCD (#10.3 mm.mm22; 64% of the
patients) were more likely to die than patients who had preserved
PCD (.10.3 mm.mm22; mortality 72% vs. 17%, p= 0.003,
Figure 2).
Discussion
This study demonstrates the direct effects of various inotropes
on the microcirculation measured at the bedside in patients with
cardiogenic shock. There was a modest correlation between
changes in global hemodynamic parameters and changes in delta-
T and PCD. Despite optimization of global hemodynamics in all
patients, 50% died. Patients with low final PCD were more likely
to die than patients in whom tissue perfusion seemed to be
restored.
Effects on systemic and pulmonary circulation
Dobutamine and enoximone are the most commonly used
intravenous inotropes for the management of cardiogenic shock in
our center. Both agents are given to increase cardiac contractility
by increasing intracellular levels of cyclic adenylate monophos-
phate (cAMP), although they affect cAMP by different mecha-
nisms. Caldicott et al. compared the effects of enoximone with
dobutamine in patients with severe heart failure following
myocardial infarction [22]. These authors reported that both
agents similarly increased cardiac output. Dobutamine, opposite to
enoximone, also significantly increased heart rate and produced
significantly more runs of supraventricular and ventricular
tachycardia. Our findings agree with this report. Norepinephrine
is an inotropic agent with high affinity for alfa-adrenergic
receptors and acts therefore mainly as a vasopressor. Norepineph-
rine increases mean arterial pressure [23], and is therefore
frequently used in the acute phase of cardiogenic shock to restore
mean arterial pressure. In addition, norepinephrine may increase
coronary blood flow in cardiogenic shock [24].
Effects on microcirculation
Patients with severe heart failure and cardiogenic shock have
impaired tissue perfusion and the severity of these abnormalities is
clearly correlated with outcome [1,5]. We recently reported the
beneficial effects of intravenous nitrates in such patients [20,25].
Lauten et al. performed serial measurements of sublingual
microcirculation, at hospital admission and the day before
discharge, in 27 patients with acute decompensated heart failure
[26]. Using standard heart failure treatment, including diuretics,
ACE-inhibitors, and betablockers, they reported a decrease in
Effects of Inotropes on Microcirculation in Cardiogenic Shock
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parameters of neurohumoral activation together with an increase
in microvascular flow index, but correlations between changes in
neurohormones and changes in microcirculation did not reach
statistical significance. Salgado et al. found beneficial effects on
sublingual microcirculation of angiotensin II inhibitors in patients
with acute severe heart failure [27].
In our study of patients with cardiogenic shock, in whom
inotropic support was judged necessary, there was no benefit of
dobutamine on parameters of microcirculatory perfusion. De
Table 1. Baseline characteristics of the study population.
Characteristic Dobutamine (n=14) Enoximone (n=10) Norepinephrine (n=9) P-value
Age, years 64 [49–74] 64 [52–71] 62 [51–80] NS
Male 8 (57%) 5 (50%) 5 (56%) NS
Medical history
AMI 4 (29%) 5 (50%) 2 (22%) NS
PCI 3 (21%) 2 (20%) 1 (11%) NS
CABG 2 (14%) 0 (0%) 2 (22%) NS
Chronic heart failure 2 (14%) 4 (40%) 3 (33%) NS
TIA/CVA 1 (7%) 2 (20%) 3 (33%) NS
Peripheral arterial disease 2 (14%) 2 (20%) 3 (33%) NS
Chronic kidney disease 2 (14%) 2 (20%) 2 (22%) NS
COPD 2 (14%) 1 (10%) 1 (11%) NS
CV risk factors
Hypertension 4 (29%) 4 (40%) 5 (56%) NS
Current smoking 2 (14%) 1 (10%) 4 (44%) NS
Dyslipidaemia 5 (36%) 4 (40%) 2 (22%) NS
Diabetes mellitus 6 (43%) 6 (60%) 3 (33%) NS
Laboratory
NT-proBNP, pmol.L21 750 [186–1124] 527 [443–938] 1629 [393–4736] NS
C-reactive protein, mg/L 52 [14–139] 29 [14–90] 91 [25–129] NS
White blood cell count, *10E9/L 10.8 [9.5–12.8] 10.7 [9.6–15.3] 11.5 [8.2–19] NS
SOFA score (total) 5 [3–6] 6 [5–7] 7 [5–8] NS
Respiratory 1 [1–2] 2 [1–2] 1 [1–2] NS
Coagulation 0 [0–0] 0 [0–0] 0 [0–1] NS
Liver 0 [0–0] 0 [0–0] 0 [0–1] NS
Cardiovascular 2 [2–3] 3 [2–3] 3 [2–4] NS
Renal 0 [0–1] 1 [0–1] 1 [0–2] NS
Echocardiography
LVEF ,30% 12 (86%) 9 (90%) 7 (78%) NS
Severe MR 3 (21%) 4 (40%) 2 (22%) NS
Poor RVF 2 (14%) 0 (0%) 0 (0%) NS
Mechanical ventilation 10 (71%) 6 (60%) 8 (89%) NS
Concomitant nitroglycerin 2 (14%) 1 (10%) 1 (11%) NS
Concomitant norepinephrine 5 (36%) 5 (50%) - NS
CVVH 1 (7%) 0 (0%) 1 (11%) NS
Revascularization
PCI 11 (79%) 7 (70%) 5 (56%) NS
CABG 0 (0%) 1 (10%) 0 (0%) NS
IABP counterpulsation 7 (50%) 7 (70%) 4 (44%) NS
Timing of baseline measurements
Time from AMI diagnosis (h) 17 [5–21] 16 [6–23] 9 [7–18] NS
Time from shock onset (h) 5 [4–7] 5 [3–6] 7 [5–9] NS
Abbreviations: AMI, acute myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; TIA, transient ischemic attack; CVA,
cerebrovascular accident; COPD, chronic obstructive pulmonary disease; CV, cardiovascular; NT-proBNP, N-terminal-pro B-type natriuretic peptide; LVEF, left ventricular
ejection fraction; MR, mitral regurgitation; RVF, right ventricular function; CVVH, continuous venovenous hemofiltration; IABP, intra-aortic balloon pump.
Values represent median [interquartile range] or number (percentage). P-values.0.05 (NS, non-significant) are not shown.
doi:10.1371/journal.pone.0103978.t001
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Backer et al. reported a modest improvement of sublingual
capillary perfusion in patients with septic shock receiving
dobutamine, but with large individual variation [28].
Enoximone improved capillary skin blood flow, measured by a
laser Doppler technique, in a study in patients undergoing
cardiopulmonary bypass surgery [29]. In addition, Kern et al.
demonstrated a beneficial effect of enoximone on hepatosplanch-
nic oxygen consumption and on liver function in fluid-optimized
septic shock patients [30]. Our study demonstrates a rather
consistent increase in PCD, which favours the use of inodilators
like enoximone over catecholamines.
The effects of norepinephrine on tissue perfusion are largely
unknown. Most studies performed in patients with septic shock
demonstrated no effect of norepinephrine on splanchnic perfusion
[31,32]. We are not aware of any reports on the direct effects of
norepinephrine on the microcirculation in cardiogenic shock.
Maier et al. recently investigated the response of the sublingual
microcirculation to the pure alfa-adrenergic agonist phenylephrine
during cardiopulmonary bypass surgery [33]. Increasing perfusion
pressure from (mean) 47 to (mean) 68 mmHg using phenylephrine
significantly decreased sublingual capillary microvascular flow
index, whereas global tissue blood flow, measured with a laser
Doppler flowmeter, increased. These findings were explained as
phenylephrine-induced microcirculatory shunting. Indeed, using
microspheres, Saxena and Verdouw demonstrated in the year
1985 the presence of arteriovenous anastomoses in the tongue
[34]. In our study, norepinephrine tended to decrease sublingual
PCD, where we should emphasize that in our patients receiving
norepinephrine median baseline MAP was relatively high
(55 mmHg).
Table 2. Parameters at baseline.
Dobutamine (n=14) Enoximone (n=10) Norepinephrine (n =9) P-value
HR, bpm 84 [59–99] 91 [78–107] 101 [84–118] NS
MAP, mmHg 66 [60–71] 68 [62–81] 55 [51–58] 0.006
CVP, mmHg 14 [11–17] 14 [9–16] 16 [12–19] NS
PCWP, mmHg 19 [16–25] 23 [17–25] 20 [17–27] NS
MPAP, mmHga 27 [21–33] 33 [28–37] 28 [25–39] NS
CI, L.min21.m22 2.2 [1.7–2.5] 1.9 [1.7–3.2] 2.6 [1.6–3.2] NS
SVR, dynes.sec.cm25 1182 [743–1502] 1057 [843–1246] 837 [555–1031] NS
SvO2, % 64 [60–68] 62 [56–71] 67 [61–70] NS
Lactate, mmol.L21 1.4 [1.1–4.6] 1.3 [1.1–2.9] 2.1 [1.1–2.8] NS
Delta-T, 6C 6.6 [4.5–6.9] 6.1 [4.3–7.5] 6.2 [3.7–13.9] NS
PCD, mm.mm22 9.3 [8.0–10.1] 9.1 [8.9–10.2] 9.8 [8.6–11.9] NS
Abbreviations: HR, heart rate; MAP, mean arterial pressure; CVP, central venous pressure; PCWP, pulmonary capillary wedge pressure; MPAP, mean pulmonary artery
pressure; CI, cardiac index; SVR, systemic vascular resistance; SvO2, mixed-venous oxygen saturation; delta-T, central-peripheral temperature gradient; PCD, perfused
capillary density.
Values represent median [interquartile range]. P-values$0.05 (NS, non-significant) are not shown.
aA pulmonary artery catheter was present in 27/33 (82%) of the measurements.
doi:10.1371/journal.pone.0103978.t002
Figure 1. Changes in perfused capillary density following infusions of dobutamine (median 60 minutes), enoximone (median
85 minutes), and norepinephrine (median 75 minutes) at the individual patient level. q, increase of parameter following inotropic
therapy in terms of percentage relative to baseline. The reference value of perfused capillary density is indicated by the red dashed line (ie,
10.3 mm.mm22). Values greater than this reference are to be considered as preserved capillary density, values below or equal to this reference reflect
impaired capillary density [5].
doi:10.1371/journal.pone.0103978.g001
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Correlations between macrocirculation and
microcirculation
The apparent lack of strong correlation between cardiac index
and microcirculatory parameters has been shown previously
[28,35]. This emphasizes that global hemodynamic parameters
do not predict microcirculatory perfusion and underlines the
importance of monitoring macro- as well as microcirculation in
patients with cardiogenic shock [36]. In our study, increases in
MAP or CVP correlated to deterioration of microcirculatory
parameters, wherease an increase in CI weakly correlated to
improvement of the microcirculation. These findings indicate that
solely improving MAP (by means of norepinephrine) might not be
a good strategy to improve tissue perfusion.
Limitations
Several limitations of our study should be acknowledged. The
small and heterogeneous sample size limits drawing strong
conclusions. Next, the fact that our study was nonrandomized
(especially dobutamine vs. enoximone) might have introduced
bias. Finally, whether the effects of inotropic agents also apply to
other microvascular beds, and whether efforts to directly improve
the microcirculation will reduce cellular dysfunction, organ failure
and mortality in patients with cardiogenic shock, needs to be
investigated.
Conclusion
This study demonstrates that after improvement of global
hemodynamic parameters, microcirculatory hypoperfusion might
still be present in the majority of patients admitted with
cardiogenic shock. To some extent, microcirculation was im-
proved by enoximone, but not by dobutamine or norepinephrine.
These findings add to the concept that therapy may potentially be
better tailored by assessment and optimization of microcirculation
in the setting of acute cardiac care. Interventions directed at
improving microvascular perfusion, such as inodilators (enox-
imone), and/or nitrates [20,25] or ultimately mechanical circula-
tory support [37], may eventually help bridge the gap between
improved hemodynamics and the dismal patient outcome in
cardiogenic shock. Whether monitoring of tissue microcirculation
optimizes current treatment strategies in patients with severe heart
failure and whether such a strategy will favourably affect outcome,
warrants further investigation.
Table 3. The effects of infusions of dobutamine (median 60 minutes), enoximone (median 85 minutes), and norepinephrine
(median 75 minutes) on parameters of macro- and microcirculation.
Dobutamine (n =14) Enoximone (n=10) Norepinephrine (n =9) P-value
DHR, bpm +9 [0; +16]** +4 [211; +9] +1 [215; +4] NS
DMAP, mmHg +6 [25; +21] +8 [+1; +14] +17 [+13; +32]** NS
DCVP, mmHg 21 [23; +1] 22 [23; 21]* +2 [24; +4] NS
DPCWP, mmHg 22 [24; 21]** 22 [23; 21]** +5 [21; +7] NS
DMPAP, mmHga 0 [23; +3] 21 [29; 0] +4 [21; +7] NS
DCI, L.min21.m22 +0.8 [+0.3; +1.4]** +0.6 [20.1; +1.5] 0.0 [20.5; +0.1] 0.006
DSVR, dynes.sec.cm25 2201 [2623; +220] 2119 [2491; +175] +390 [+237; +505]* 0.03
DSvO2, % +6 [+2; +12]** 0 [23; +4] 0 [23; +6] 0.04
DLactate, mmol.L21 20.4 [22.5; 20.1]** 0.0 [20.6; +0.2] 0.0 [20.2; +0.5] NS
DDelta-T, 6C 20.4 [20.8; 0] 21.1 [21.9; +0.6] 0.0 [22.2; +0.6] NS
DPCD, mm.mm22 +0.6 [20.9; +2.3] +2.0 [+0.5; +3.4]* 20.4 [23.3; 0.0] 0.01
Abbreviations: HR, heart rate; MAP, mean arterial pressure; CVP, central venous pressure; PCWP, pulmonary capillary wedge pressure; MPAP, mean pulmonary artery
pressure; CI, cardiac index; SVR, systemic vascular resistance; SvO2, mixed-venous oxygen saturation; delta-T, central-peripheral temperature gradient; PCD, perfused
capillary density.
Values represent median [interquartile range]. The p-value in the last column represents differences among groups. Asterisks indicate statistical significance versus
baseline:
*, p,0.05;
**, p,0.01.
P-values.0.05 (NS, non-significant) are not shown.
aA pulmonary artery catheter was present in 27/33 (82%) of the measurements.
doi:10.1371/journal.pone.0103978.t003
Table 4. Correlations between changes in pooled global hemodynamic and microcirculatory parameters.
DDelta-T, 6C DPCD, mm.mm22
DMAP r=0.52, p = 0.007 r=20.44, p = 0.01
DCI r=20.48, p = 0.01 r= 0.38, p = 0.03
DCVP r=0.35, p = 0.08 r=20.36, p = 0.05
r= Spearman’s correlation coefficient.
doi:10.1371/journal.pone.0103978.t004
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